---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-301873"
form_type: "8-K"
ticker: "SPRY"
cik: "0001671858"
company_name: "ARS Pharmaceuticals, Inc."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T06:49:48.277380+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# ARS Pharmaceuticals appoints Brian Dorsey as COO; salary increased to $410,000

## Summary
- Brian Dorsey appointed COO effective December 6, 2022; previously SVP of Operations and Project Management since 2018.
- Base salary raised from $319,800 to $410,000; eligible for annual discretionary bonus up to 40% of base salary.
- Employment agreement is part-time (~35%); Dorsey may engage in other business activities, subject to non-compete in nasal drug development.
- Severance: 3 months base salary and COBRA premiums if terminated without cause or resigns for good reason after 12-month cliff.
- Dorsey holds 120,000-share option grant under 2018 Equity Incentive Plan, vesting monthly over 3 years.

## SEC filing metadata
- accession: 0001193125-22-301873
- form_type: 8-K
- ticker: SPRY
- cik: 0001671858
- company_name: ARS Pharmaceuticals, Inc.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671858/000119312522301873/0001193125-22-301873-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671858/000119312522301873/d772949d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-301873
- JSON: https://secwatch.observer/filing/0001193125-22-301873.json
- Plain text: https://secwatch.observer/filing/0001193125-22-301873.txt

## Key facts
- Executive change
  Brian T. Dorsey was appointed as Chief Operations Officer at ARS Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Chief Operations Officer
  source text: Effective as of December 6, 2022, ARS Pharmaceuticals, Inc. (the “Company”) appointed Brian T. Dorsey, MSc, as Chief Operations Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671858/000119312522301873/0001193125-22-301873-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.